Paul Craddy and Graham Foxon are looking forward to attending the #BIOConvention in Boston next week, where they will be networking with biotech and pharma companies who want to identify the potential price and value of their asset, from a payer perspective. 

Drop us a line if you are attending the event and wish to discuss any pricing or market access challenges you may be facing. Hope to see you there!